EIF eiffel technologies limited

any thoughts on whats happening here?, page-8

  1. 1,539 Posts.
    Crookers...this is what I believe I saw written up...
    "The data suggest that Oralin, Generex' proprietary oral insulin spray, may be a safe and effective replacement for injected insulin in the treatment of type 1 and type 2 diabetes patients. Oralin is delivered as a fine spray to the buccal (oral) cavity via Generex' RapidMist device, where the formulation is rapidly absorbed through the buccal mucosa and into the bloodstream.

    The study entitled "Biokinetics of Oral Spray Insulin: Comparison with Regular and Lispro Insulin in Patients with Type-1 Diabetes" found that the biokinetics of oral spray insulin was similar to lispro insulin reaching peak plasma insulin levels 30 minutes after administration and lowest levels at 240 min. As expected, regular insulin reached peak and steady state levels between 30 and 120 min. Blood glucose levels declined following insulin absorption independently of the type of insulin used. Oral spray insulin was absorbed through the buccal mucosa with biookinetics similar to lispro insulin. "

    Cant find the f'kn article amongst the pile of papers, but this looks like it from memory.Pls keep me informed if you get a response from EIF.
    Rick

 
watchlist Created with Sketch. Add EIF (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.